Zobrazeno 1 - 10
of 122
pro vyhledávání: '"José Manuel Vázquez-Rodríguez"'
Autor:
Ángel Isidro Hernández García, Sarai Alejandro-Hernández, Zujey Berenice Cuevas-Carballo, Jorge Alberto Galaviz-Pérez, José Manuel Vázquez-Rodríguez, David Guerrero-Zárate
Publikováno v:
Applied Sciences, Vol 14, Iss 17, p 7950 (2024)
This work proposes a conceptual design for recovering polystyrene (PS) using solvents of agro-industrial origin. The literature describes the dilution of expanded polystyrene (EPS) in limonene, followed by its insolubilization with alcohols for recov
Externí odkaz:
https://doaj.org/article/29a7f852eeaa4791bb04bc4cdffb3e3e
Autor:
Ricardo Pan-Lizcano, Lucía Núñez, Pablo Piñón, Guillermo Aldama, Xacobe Flores, Ramón Calviño-Santos, José Manuel Vázquez-Rodríguez, Manuel Hermida-Prieto
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0304041 (2024)
Ventricular fibrillation (VF) in acute myocardial infarction (AMI) is the main cause of deaths occurring in the acute phase of an ischemic event. Although it is known that genetics may play an important role in this pathology, the possible role of lo
Externí odkaz:
https://doaj.org/article/0c0bd662cdb64c87b644616473f128fd
Autor:
Lucía Núñez, Grecia M Marrón-Liñares, María G Crespo-Leiro, Eduardo Barge-Caballero, Eloy Álvarez-López, Natalia Suarez-Fuentetaja, María Jesús Paniagua-Martin, Jorge Pombo, Javier Muñiz, Carmela D Tan, E René Rodríguez, José Manuel Vázquez-Rodríguez, Manuel Hermida-Prieto
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0219345 (2019)
IntroductionOne of the main problems involved in heart transplantation (HT) is antibody-mediated rejection (AMR). Many aspects of AMR are still unresolved, including its etiology, diagnosis and treatment. In this project, we hypothesize that variants
Externí odkaz:
https://doaj.org/article/8a106d5507ab41638ecc17628f000a08
Autor:
Francisco Marin, Marcelo Sanmartín Fernández, Iñaki Lekuona, Fernando Arribas, Gonzalo Barón-Esquivias, Vivencio Barrios, Juan Cosin-Sales, Román Freixa-Pamias, Jaime Masjuan, Alejandro I Pérez-Cabeza, Vanessa Roldán Schilling, José Manuel Vázquez Rodríguez, Carles Rafols Priu, Manuel Anguita Sánchez
Publikováno v:
Journal of Comparative Effectiveness Research. 11:1173-1184
Objective: To analyze the effectiveness and safety of rivaroxaban in patients with atrial fibrillation (AF). Methods: The clinical profile and outcomes of the EMIR study were indirectly compared with those of ROCKET-AF, eight other Spanish observatio
Autor:
María A Esteve-Pastor, José M Rivera-Caravaca, Vanessa Roldán, Marcelo Sanmartin Fernández, Fernando Arribas, Jaime Masjuan, Vivencio Barrios, Juan Cosin-Sales, Román Freixa-Pamias, Esther Recalde, Alejandro I Pérez-Cabeza, José Manuel Vázquez Rodríguez, Carles Ràfols Priu, Manuel Anguita Sánchez, Gregory Y H Lip, Francisco Marin
Publikováno v:
Esteve-Pastor, M A, Rivera-Caravaca, J M, Roldán, V, Fernández, M S, Arribas, F, Masjuan, J, Barrios, V, Cosin-Sales, J, Freixa-Pamias, R, Recalde, E, Pérez-Cabeza, A I, Rodríguez, J M V, Priu, C R, Sánchez, M A, Lip, G Y H & Marin, F 2023, ' Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban : Observations from the prospective EMIR Registry ', European heart journal. Cardiovascular pharmacotherapy, vol. 9, no. 1, pp. 38-46 . https://doi.org/10.1093/ehjcvp/pvac060
Background Assessing bleeding risk during the decision-making process of starting oral anticoagulation (OAC) therapy in atrial fibrillation (AF) patients is essential. Several bleeding risk scores have been proposed for vitamin K antagonist users but
Publikováno v:
Nova Scientia, Vol 9, Iss 18, Pp 515-536 (2017)
Introducción : El objetivo de este acercamiento fue validar a través de un análisis factorial confirmatorio un modelo de medida para determinar las limitantes percibidas para desarrollar interés por las actividades científica s o tecnológicas e
Externí odkaz:
https://doaj.org/article/300f4c45429d49d1888003b4d7d43782
Autor:
Marcelo Sanmartín Fernández, Manuel Anguita Sánchez, Fernando Arribas, Gonzalo Barón-Esquivias, Vivencio Barrios, Juan Cosin-Sales, María Asunción Esteve-Pastor, Roman Freixa-Pamias, Iñaki Lekuona, Alejandro I. Pérez-Cabeza, Isabel Ureña, José Manuel Vázquez Rodríguez, Carles Rafols Priu, Francisco Marin
Publikováno v:
Cardiology Journal. 29:601-609
The aim of the study was to evaluate the performance of the 2MACE in patients with atrial fibrillation (AF) treated with rivaroxaban and to improve the accuracy of 2MACE.This was a post-authorization and observational study of AF adults treated with
Autor:
José Manuel Vázquez Rodríguez, Eduardo Pinar Bermúdez, José Luis Zamorano, José Moreu Burgos, José Francisco Díaz-Fernández, Bruno García del Blanco, Archita Sarmah, Pascal Candolfi, Judith Shore y, Michelle Green
Publikováno v:
REC: interventional cardiology.
Autor:
José Manuel Vázquez Rodríguez, Eduardo Pinar Bermúdez, José Luis Zamorano, José Moreu Burgos, José Francisco Díaz-Fernández, Bruno García del Blanco, Archita Sarmah, Pascal Candolfi, Judith Shore, and, Michelle Green
Publikováno v:
REC: interventional cardiology (English Edition).
Autor:
Francisco Marín, Marcelo Sanmartín Fernández, Gonzalo Barón-Esquivias, Vivencio Barrios, Iñaki Lekuona, Alejandro I Pérez-Cabeza, Jaime Masjuan, Esther Recalde del Vigo, José Manuel Vázquez Rodríguez, Roman Freixa-Pamias, Vanessa Roldán Schilling, Fernando Arribas, Carles Rafols Priu, Manuel Anguita Sánchez
Publikováno v:
Journal of Comparative Effectiveness Research. 12
Aim: It is not well known how comorbidities may change the prognosis of atrial fibrillation (AF) patients. This study was aimed to analyze the impact of cardiovascular disease on this population. Materials & methods: EMIR was a multicenter, prospecti